These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15770932)

  • 1. Mupirocin once weekly reduces the incidence of catheter exit-site infection in peritoneal dialysis patients.
    Al-Hilali NA; Ninan VT; Al-Humoud HA; Nampoory MR; Johny KV
    Perit Dial Int; 2005; 25(1):91-2. PubMed ID: 15770932
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
    Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
    Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis.
    Cavdar C; Atay T; Zeybel M; Celik A; Ozder A; Yildiz S; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():67-70. PubMed ID: 15384798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients.
    Casey M; Taylor J; Clinard P; Graham A; Mauck V; Spainhour L; Brown P; Burkart J
    Perit Dial Int; 2000; 20(5):566-8. PubMed ID: 11117248
    [No Abstract]   [Full Text] [Related]  

  • 7. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to mupirocin: no indication of it to date while using mupirocin ointment for prevention of Staphylococcus aureus exit-site infections in peritoneal dialysis patients.
    Vas SI; Conly J; Bargman JM; Oreopoulos DG
    Perit Dial Int; 1999; 19(4):313-4. PubMed ID: 10507810
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
    Jassal SV; Lok CE;
    Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mupirocin application at the exit site in peritoneal dialysis patients: five years of experience.
    Aykut S; Caner C; Ozkan G; Ali C; Tugba A; Zeynep G; Taner C
    Ren Fail; 2010 Jan; 32(3):356-61. PubMed ID: 20370452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal mupirocin does not prevent exit-site infections in children receiving peritoneal dialysis.
    Araki Y; Hataya H; Ikeda M; Ishikura K; Honda M
    Perit Dial Int; 2003; 23(3):267-9. PubMed ID: 12938828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections.
    Chu KH; Choy WY; Cheung CC; Fung KS; Tang HL; Lee W; Cheuk A; Yim KF; Chan WH; Tong KL
    Perit Dial Int; 2008; 28(5):505-8. PubMed ID: 18708544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exit site infections: systematic microbiologic and quality control are needed.
    Freitas C; Rodrigues A; Carvalho MJ; Cabrita A
    Adv Perit Dial; 2009; 25():26-31. PubMed ID: 19886313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.